MapLight Therapeutics, Inc.
MPLTNasdaqCIK 1770069HealthcareFiscal year ends Dec 31
Reports and events: 25 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1820:15 ET | S-1/A | Registration statement, amended | 0001193125-26-395559 |
| 2026-09-0921:28 ET | S-1 | Registration statement | 0001193125-26-386648 |
| 2026-08-1822:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-098444 |
| 2026-08-1321:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349554 |
| 2026-08-1320:51 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-349490 |
| 2026-08-0301:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-089960 |
| 2026-07-3113:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001388325-26-000034 |
| 2026-07-2711:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-316820 |
| 2026-06-2411:12 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-280243 |
| 2026-06-2211:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-276691 |
| 2026-06-1821:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-276065 |
| 2026-05-1420:25 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-224129 |
| 2026-05-1420:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-224067 |
| 2026-04-2920:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-191566 |
| 2026-04-2920:02 ET | DEF 14A | Proxy statementPeriod 2026-06-23 | 0001193125-26-191449 |
| 2026-03-2611:20 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-125072 |
| 2026-03-2611:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-125062 |
| 2026-01-0912:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-008267 |
| 2025-12-0412:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-307453 |
| 2025-12-0412:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-307450 |
| 2025-11-2000:37 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-114697 |
| 2025-11-0421:21 ET | SCHEDULE 13D | Ownership report, active investor | 0001388325-25-000021 |
| 2025-10-2913:12 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-255041 |
| 2025-10-0620:02 ET | S-1/A | Registration statement, amended | 0001193125-25-231829 |
| 2025-09-1920:11 ET | S-1 | Registration statement | 0001193125-25-209084 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.